REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 448 filers reported holding REPLIGEN CORP in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $297,000 | -19.9% | 1,120 | -12.8% | 0.02% | -27.3% |
| Q3 2021 | $371,000 | +44.9% | 1,284 | 0.0% | 0.03% | +43.5% |
| Q2 2021 | $256,000 | +2.8% | 1,284 | +0.1% | 0.02% | -14.8% |
| Q1 2021 | $249,000 | -0.4% | 1,283 | -1.8% | 0.03% | -6.9% |
| Q4 2020 | $250,000 | -29.0% | 1,306 | -45.2% | 0.03% | -39.6% |
| Q3 2020 | $352,000 | +23.5% | 2,384 | +3.5% | 0.05% | +11.6% |
| Q2 2020 | $285,000 | -18.1% | 2,304 | -36.1% | 0.04% | -34.8% |
| Q1 2020 | $348,000 | +31.3% | 3,603 | +26.0% | 0.07% | +40.4% |
| Q4 2019 | $265,000 | +18.8% | 2,860 | -1.5% | 0.05% | +6.8% |
| Q3 2019 | $223,000 | -24.1% | 2,905 | -15.1% | 0.04% | -22.8% |
| Q2 2019 | $294,000 | +45.5% | 3,423 | 0.0% | 0.06% | +46.2% |
| Q1 2019 | $202,000 | – | 3,423 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |